Tungsten trioxide (WO3) is one of a few stable semiconductor materials liable to produce solar fuel by photoelectrochemical water splitting. To enhance its visible light conversion efficiency, we incorporated plasmonic gold nanoparticles (Au NPs) derivatized with polyoxometalate (H3PMo12O40) species into WO3. The combined plasmonic and catalytic effect of Au NPs anchored to the WO3 surface resulted in a large increase of water photooxidation currents. Shielding the Au NPs with polyoxometalates appears to be an effective means to avoid formation of recombination centers at the photoanode surface.
Chemically-reduced graphene-oxide-supported gold nanoparticles with a diameter, of 40-60 nm are considered here as catalytic materials for the reduction of oxygen in alkaline medium in comparison to analogous systems based on conventional Vulcan carbon carriers. Gold nanoparticles are prepared by the chemical reduction method, in which the NaBH4-prereduced Keggin-type phosphomolybdate heteropolyblue acts as the reducing agent for the precursor (HAuCl4). Polyoxometallate (PMo12O403) capping ligands stabilize gold nanoparticle deposits, facilitate their dispersion and attachment to carbon supports. Indeed, it is apparent from the independent diagnostic voltammetric experiments (in 0.5 mol dm (H2SO4)-H-3) that heteropolymolybdates form readily stable adsorbates on nanostructures of both gold and carbon (reduced graphene oxide and Vulcan). It is reasonable to expect that the polyoxometallate-assisted nucleation of gold has occurred in the proximity of oxygenated defects existing on carbon substrates. Under conditions of electrochemical diagnostic experiments (performed in 0.1 mol dm (3) KOH): (i) the phosphomolybdate adsorbates are removed from the interface as they undergo dissolution in alkaline medium; and (ii) the Au nanoparticles (Au loading, 30 mu g cm (2)) remain well-dispersed on the carbon as evident from transmission electron microscopy. High electrocatalytic activity of the reduced-graphene oxide-supported Au nanoparticles toward reduction of oxygen in alkaline medium is demonstrated using cyclic and rotating ring-disk voltammetric experiments. The latter system could also act as the active support for Pt nanoparticles during the reduction of oxygen. Among important issues are possible activating interactions between gold and the support, as well as presence of structural defects existing on poorly organized graphitic structure of reduced graphene oxide (as evident from Raman spectroscopy)
We report on the development of two new Pt-free electrocatalysts (ECs) for the oxygen reduction reaction (ORR) based on graphene nanoplatelets (GNPs). We designed the ECs with a core-shell morphology, where a GNP core support is covered by a carbon nitride (CN) shell. The proposed ECs present ORR active sites that are not associated to nanoparticles of metal/alloy/oxide, but are instead based on Fe and Sn sub-nanometric clusters bound in coordination nests formed by carbon and nitrogen ligands of the CN shell. The performance and reaction mechanism of the ECs in the ORR are evaluated in an alkaline medium by cyclic voltammetry with the thin-film rotating ring-disk approach and confirmed by measurements on gas-diffusion electrodes. The proposed GNP-supported ECs present an ORR overpotential of only ca. 70 mV higher with respect to a conventional Pt/C reference EC including a XC-72R carbon black support. These results make the reported ECs very promising for application in anion-exchange membrane fuel cells. Moreover, our methodology provides an example of a general synthesis protocol for the development of new Pt-free ECs for the ORR having ample room for further performance improvement beyond the state of the art.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.